Inflammation Improve Articles & Analysis

2 news found

EsoCap announces first patient enrolled in Phase II eosinophilic esophagitis trial

Randomized, placebo-controlled, double-blind Phase II trial to treat 42 patients ongoing in four European countries with ESO-101 ESO-101, EsoCap’s lead product candidate, consists of a capsule with a rolled, thin mucoadhesive film, loaded with the anti-inflammatory corticosteroid, mometasone furoate In a previous trial, EsoCap’s proprietary and unique targeted application ...

Oct. 25, 2021

ByEsoCap AG

Nuritas announce peer reviewed publication of world’s first AI discovered anti-inflammatory

Nuritas, the world leader in artificial intelligence-based natural molecule discovery, has published an independent peer reviewed scientific paper in Foods Journal. The paper outlines the discovery of natural rice-based peptides clinically proven to impact inflammation and improve physical test results in an elderly population. Whilst these peptides are found within food, critically, their ...

Sep. 3, 2020

ByNuritas Ltd.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you